Risks of cancer incie in people born in Fgland and Wales and New Zealand (non-Maoris) living in their home countie and after migration between the two countris, were analysed using data from their national cancer registries. Since 
Migrant studies have played an important part in demonstrating the environmental origins of many cancers, by showing sizeable changes in risk with residence in the new country (Haenszel, 1982) . Migrant groups, however, are often very different genetically from the native population of the country to which they migrate, and therefore it is difficult to know whether residual differences in cancer risk between the immigrants and the natives of the host country are genetic or are due to differences in behaviour or early environment. Risks in migrants can give information on the likely age at which caranogens act, since the early exposures of the migrants will be in their native country and the later exposures in the host country. Comparative data on migrants in both directions between two countries ought to be particularly informative, since factors actng early in life should increase risk in migrants from the high-to low-risk country but not in migrants in the opposite direction, while factors acting late should have the reverse effect. To our knowledge, however, there have been no such studies in two-way migration.
The first Europeans known to have reached New Zealand were Tasman, a Dutchman, and his crew in 1642, but the great majority of early colonists were British. Subsequent migration from Britain to New Zealand has been of such an extent that, unusually, the New Zealand non-aboriginal (nonMaori) population is largely of British descent (McLintockc, 1966) . There has also been appreciable migration in the opposite direction. The preset study uses data from the national cancer registries of England and Wales and New Zealand to assess comparative cancer risks in residents born in the two countries and migrants between them.
Material and nhom
Cancer registration in England and Wales has been conducted on a national basis since 1945, with complete geographic coverage of the country sine 1962 (Swerdlow, 1986) . Country of birth has been recorded in the national cancer registration files since 1971. The data presented here relate to the years of incidence for which registrations were reasonably complete at the time that data were extracted for this study: 1971-83. In New Zealand, cancer registration has been conducted nationally since 1948, and became population based in 1972 (Fmdlay et al., 1987) . The data analysed in this study are for (Cooke and Fraser, 1985) .
Resnls
The native-born population of England (Ferns, 1974 (141, (143) (144) (145) Nasopharynx (147) Other pharynx (146, (148) (149) Cesophagus (150) Stomach (151) Small intestine (152) Colon (153) Rectum (154) Liver (155) Gal bladder (156) Pancreas (157) Nose (160) Larynx (161) Lung (162) Pleura (163) Thymus (164.0) Bone (170) Soft tissue (171) Melanoma (172) Breast (175) Prostate (185) Testis (186) Other male genital (187) Bladder (188) Kidney (189) Eye (190) Brain and other nervous system (191) (192) il-defined (195) (196) (197) (198) (199) Hodgkin's disease (201) Non-Hodgkin's lymphoma (200, 202) Multiple myeloma (203 (152) Colon (153) Rectum (154) Liver (155) Gall bladder (156) Pancreas (157) Nose (160) Larynx (161) Lung (162) Pleura (163) Thymus (164.0) Bone (170) Soft tissue (171) Melanoma (172) Breast (174) Uterus unspecified (179) Cervix (180) Placenta (181 (Swerdlow et al., 1993) and in New Zealand in 1972-84 was reported to be at least 95% complete (Findlay, 1989) . There was also a difference between these registris in the proportion of registrations for which country of birth was known: 69% in England and Wales and 95% in New Zealand. These differences would bias a comparison of ancer incidnc rates between the two countries (since incompkteness would lead to reduced rates). They should not, however, affect the odds ratios used in the present analyses (since incompleteness should affect the exposure status of the cases and controls similarly), unkss the proportion of incident canrs that were not registered with a known country of birth varied by cancer site or age in ways appreciably different between the countries or nativity groups. Odds ratios, however, are susceptible to bias if the controls (i.e. all cancers except the site under study) are not representative of the catchment population. This will depend particularly on the distribution between NZ, England and Wal, and the migrant groups of the commonest tumoursfor instanc the high lung caer risk in English and Welsh in England and Waks will tend to have a reciprocal effect of artefactually reducing apparent risks for all other sites in that population group, since in each group the total of all canrs must be 100%. To gain some ition of where such bias might be occurring, we conducted analyses also usng a 'weighted' control set, where the contribution of the commonest tumours was no greater than that of less common maii. Results that were robust to whether weighted or unweighted analyses were conducted are less likely to be artefactual. A second check on potential bias for the two non-migrant groups in the study is to examine published registration rates for NZ (non-Maoris) and England and Wales (Muir et al., 1987) , as these will largely be formed by the non-migrants. The all-ages all-cancer rate was slightly greater for NZ than for England and Wales, which with the slightly lower registration complteness for England and Wales compared with NZ implies that incdence rates in the two countries are probably very similar, and reiprocty bias probably slght. At young ages, however, all-cancer registration rates are considrably greater in NZ than in England and Waks, and therefore the odds ratios for New Zealanders in NZ may be too low for the few tumours (such as tesicular cancer and Hodgkin's disease) which occur mainy at younger ages. In generaL the odds ratios for these caners are significanty raisd, so that the bias would simply lead to an underestimate of the magnitude rather than a mistake in the direction of the cancer risks. Specifically for Hodgkin's diseas, however, the odds ratios for New Zealanders in NZ were reduced, and therefore for this tumour the direction of the nsk may also have been estimated unreliably by the method.
Migrant data might be biased if appreciabe numbers of cancer patients travelled from one country to the other for treatment, and were then mistakenly coded as residents at cancer registration. Such travel is negigible (if not nonexistent) between England and Wales and New Zealand. Differences between the study groups in the proportion of registered canes for which the primary site was unknown would affect site-specific cancer odds ratios. The proportion of cancers with site unknown was small in each data set however (4.3% in English and Welsh in England and Wales, 2.8% in New Zelanders in England and Waks, 3.6% in English and Welsh in NZ and 3.9% in New Zealanders in NZ). Its effect will therefore have been very slight. Bias could occur if registry coding pracics differed between the two countries. On enquiry, however there are no special coding practic in either registry that could account for the results.
A large number of comparisons were tested for significnce in the study, and some would be expected to be significant by chance alone. Interpretation needs to seek connt patterns in relation to migration, rather than simply considering individual signnt results.
Migrants are sekcted individuals who may be atypical of ther natie country with respect to cancer risk factors. Also, the experience of migration may lead to atypicality with respect to risk factors. This might explain the greater risk of breast cancer in both of the migrant groups than in either of the locally born populations: nulliparous women may more easily be able to migrate than women with famili, and the perince of migration may cause delay in garting a family. Bearing these potential artefacts in mind, there are certain interesting features of the data. Risks of melanoma and lip cancer were much greater in New Zelanders in NZ than in English and Welsh in England and Wals, as would be expected from the greater solar ultraviolet (UV) flux (McKenzie and Elwood, 1990 ) and more outdoor lifestyle in NZ than England and Wales. The greater proportion of Celtic-origin Britons in the population of New Zealand than that of England and Wales may also have had a small effet, but could not explain the scale of difference in risks. The risks of these malignanies in migrants are of interest in relation to the age at which aetiological factors for the tumours act. Recent epidemiological studies of melanoma have focused particularly on the role of childhood exposure to UV. The raised risks of melanoma in New Zealanders in Englad and Wales add to recent data on migants from high-to low-risk areas of the US (Mack and Floerus, 1991) in supporting an early exposure risk. The greater risk for New Zealanders than for English and Welsh in NZ would also accord with this. Mortality data for NZ have shown greater melanoma risk (almost at native NZ klevls) for English and Welsh who migrated before age 30 than for those who migrated at an oler age than this (Cooke and Fraser, 1985 (Haensel, 1982) . Analysis of mortality and incidence rates of colon cancr in successive birth cohorts in New Zealand, however, has sug d the importance of aetiological factors before 30 years of age (Cox and Little, 1992) . In contrast to colon cancer, the high risks of prostatic and thyroid caners (and, based on smaIl numbers, thymus cancers) in NZ compared with England and Wales appeared to be acquired by immigrants to NZ, suggsting that exposures later in life can increase risks. For prostatic cancer, migrants from lower risk counties to the US have also acquired the raised risk of their host country within the first generation (Haenszel, 1982) . The prostate and thyroid, however, are both sites where there is parcular potential for apparent canr incidence to be influenced by the extent of diagnotic investigation, since many asymptomatic cases occur. Thymus ancer registration rates can be affected by decisions about the borderline between malignant and benign thymomas, since most are morpholoclly indistingushable (Snover et al., 1982 ). An alternative possible reason for differences in rates of these tumours between England and Wales and NZ, therefore, would be diagnostic artefact, although this would not explain the high prostatic cancer risk in New Zland migants to Englad and Wales.
Lung cancer risks were lower in New Zealanders in NZ than in English and Welsh in England and Waks. This accords with survey data on smoking habits in the two countries, although these surveys are more recent than would be ideal in relation to the aetiology of the lung canrs in the study: in the 1981 NZ census (Department of Sta , 1983) 33% of men and 28% of women among the New Zealandborn were current smokers compared with 47% and 36% of adults in Britain (OPCS, 1984) , and 20% and 14% of the New Zealand-born were smnokers of 15 or more cigarettes per day compared with 31% and 18% in Britain in 1976 (OPCS, 1978 1980 and 1982.) National data on tobacco consumption for the decades before the dias of the ancers in this study (Beese, 1972) (Department of Statistics, 1983) was greater than in either Britain (29% and 15% respectively, OPCS, 1984) 
